A Phase III Multinational Multicenter Investigator-Masked Randomised Active-Controlled Trial Comparing the Efficacy and Safety of DE-130A With Xalatan ® in Patients With Open-Angle Glaucoma or Ocular Hypertension

Conditions:   Open-Angle Glaucoma or Ocular Hypertension;   Ocular Surface Disease Interventions:   Drug: DE-130A;   Drug: Xalatan® Sponsor:   Santen SAS Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials